Platform 1: Imaging & Scanning


Medical imaging is a critical part of the medical technology industry. Worldwide it is a US$30B per year industry, growing at around 7% per year. New Zealand is a world leader in many imaging technologies, including MARS spectral imaging and cardiac MRI. The purpose of the Imaging and Scanning Technology Platform for the MedTech CoRE, is to foster new methods and tools for the imaging and scanning needs of the MedTech CoRE flagship projects, and progress the NZ development of imaging technologies. Several medical and pre-clinical imaging methodologies are under active development, including methods for measuring biomarkers. These biomarkers can be either intrinsic such as fat/water concentration and blood flows, or extrinsic using injected pharmaceuticals. These allow measurement and monitoring of disease and its treatment over time.


Principal Investigators

University of Otago, Christchurch

University of Auckland

Our Work


  • University of Otago, Christchurch (New Zealand)
  • University of Auckland (New Zealand)
  • Hospital General Universitario Gregorio Maranon (Madrid, Spain)
  • Oregon Health Sciences University (Oregon, USA)
  • University of Turin (Italy)
  • Lausanne University Hospital (Switzerland)
  • Lincoln University (New Zealand)
  • Victoria University (New Zealand)
  • Brain Research New Zealand
  • MacDiarmid Institute for Advanced Materials and Nanotechnology (Wellington and Christchurch, New Zealand)
  • Members of Maurice Wilkins Centre (Dunedin, New Zealand)
  • GE Healthcare
  • Redlen Ltd (Canada)
  • Advacam (Finland)